Persistent URL of this record https://hdl.handle.net/1887/105132
In Collections
This item can be found in the following collections:
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients (pts) with gastrointestinal stromal tumor (GIST) treated with sunitinib (SU) in a worldwide treatment-use (TU) trial
- All authors
- Reichardt, P.; Demetri, G.D.; Gelderblom, H.; Rutkowski, P.; S.A. im; Gupta, S.; Kang, Y.K.; Schoffski, P.; Schuette, J.; Soulieres, D.; Blay, J.Y.; Goldstein, D.; Fly, K.D.; Huang, X.; Corsaro, M.; Lechuga, M.; Martini, J.F.; Heinrich, M.C.
- Date
- 2014-05-20
- Journal
- Journal of Clinical Oncology
- Volume
- 32
- Issue
- 15